ESR1 and breast carcinoma: They include the luminal (ER/PR-positive and HER2-negative), HER2 (HER2-positive regardless of ER/PR status), and triple-negative (TN; ER-, PR-, and HER2-negative) breast cancer subtypes [3,4].